Literature DB >> 18617155

Clinical therapy of schistosomiasis mansoni: the Brazilian contribution.

N Katz1, P M Z Coelho.   

Abstract

The review gives a detailed account of the history of drug development, treatment and drug resistance for clinical therapy of schistosomiasis mansoni, specially emphasizing the importance of Brazilian contribution on antischistosomal chemotherapy, as well as on the control of this parasitic disease.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18617155     DOI： 10.1016/j.actatropica.2008.05.006

Source DB:  PubMed          Journal:  Acta Trop        ISSN： 0001-706X            Impact factor:   3.112


  11 in total

1.  Effect of nanoparticles on the therapeutic efficacy of praziquantel against Schistosoma mansoni infection in murine models.

Authors:  Alaa Eldin M Labib El Gendy; Faten Alsayed Mohammed; Sara A Abdel-Rahman; Thanaa Ibrahim Ahmed Shalaby; Ghada M Fathy; Samira Metwally Mohammad; Mahmoud A El-Shafey; Nesma Atef Mohammed
Journal:  J Parasit Dis       Date:  2019-04-03

Review 2.  Thioredoxin glutathione reductase: its role in redox biology and potential as a target for drugs against neglected diseases.

Authors:  Stefanie Prast-Nielsen; Hsin-Hung Huang; David L Williams
Journal:  Biochim Biophys Acta       Date:  2011-07-14

3.  Evaluation of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles.

Authors:  Edna de Farias Santiago; Sheilla Andrade de Oliveira; Gevânio Bezerra de Oliveira Filho; Diogo Rodrigo Magalhaes Moreira; Paulo André Teixeira Gomes; Anekécia Lauro da Silva; Andréia Ferreira de Barros; Aline Caroline da Silva; Thiago André Ramos Dos Santos; Valéria Rêgo Alves Pereira; Gabriel Gazzoni Araújo Gonçalves; Fábio André Brayner; Luiz Carlos Alves; Almir Gonçalves Wanderley; Ana Cristina Lima Leite
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

Review 4.  Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.

Authors:  Rashad Abdul-Ghani; Naguiba Loutfy; Amel el-Sahn; Azza Hassan
Journal:  Parasitol Res       Date:  2009-03-03       Impact factor: 2.289

5.  In vitro activity of aryl-thiazole derivatives against Schistosoma mansoni schistosomula and adult worms.

Authors:  Adriana S A Pereira; Gilbert O Silveira; Murilo S Amaral; Sinara M V Almeida; Jamerson F Oliveira; Maria C A Lima; Sergio Verjovski-Almeida
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

6.  Monoclonal antibody-based dipstick assay: a reliable field applicable technique for diagnosis of Schistosoma mansoni infection using human serum and urine samples.

Authors:  Zeinab Demerdash; Salwa Mohamed; Mohamed Hendawy; Ibrahim Rabia; Mohy Attia; Zeinab Shaker; Tarek M Diab
Journal:  Korean J Parasitol       Date:  2013-02-18       Impact factor: 1.341

7.  Mefloquine--an aminoalcohol with promising antischistosomal properties in mice.

Authors:  Jennifer Keiser; Jacques Chollet; Shu-Hua Xiao; Jin-Yan Mei; Pei-Ying Jiao; Jürg Utzinger; Marcel Tanner
Journal:  PLoS Negl Trop Dis       Date:  2009-01-06

8.  The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype.

Authors:  António Pinto-Almeida; Tiago Mendes; Ana Armada; Silvana Belo; Emanuel Carrilho; Miguel Viveiros; Ana Afonso
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

9.  Morphological Characteristics of Schistosoma mansoni PZQ-Resistant and -Susceptible Strains Are Different in Presence of Praziquantel.

Authors:  António Pinto-Almeida; Tiago Mendes; Rosimeire Nunes de Oliveira; Sheila de Andrade Penteado Corrêa; Silmara Marques Allegretti; Silvana Belo; Ana Tomás; Fernanda de Freitas Anibal; Emanuel Carrilho; Ana Afonso
Journal:  Front Microbiol       Date:  2016-04-26       Impact factor: 5.640

10.  An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans.

Authors:  Meghan A Guzman; Anastasia R Rugel; Reid S Tarpley; Sevan N Alwan; Frédéric D Chevalier; Dmytro P Kovalskyy; Xiaohang Cao; Stephen P Holloway; Timothy J C Anderson; Alexander B Taylor; Stanton F McHardy; Philip T LoVerde
Journal:  PLoS Negl Trop Dis       Date:  2020-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.